JoVE Core

Pharmacokinetics and Pharmacodynamics

A subscription to JoVE is required to view this content.

live

Speed

×

MEDIA_ELEMENT_ERROR: Format error

5.13 : Phase II Reactions: Miscellaneous Conjugation Reactions

Phase II biotransformations are detoxification mechanisms that conjugate xenobiotics with endogenous substances, neutralizing their toxicity.

A key example involves the conjugation of cyanide ions, which impair cellular respiration and alter hemoglobin into non-oxygen-carrying cyanmethemoglobin. To neutralize this threat, a sulfur atom from thiosulphate is transferred to the cyanide ion, catalyzed by the enzyme rhodanese, resulting in an inactive compound called thiocyanate. The production of thiosulfate occurs through the transamination of β-cysteine to mercaptopyruvate.

Another significant phase II reaction involves conjugating endogenous purine and pyrimidine bases with ribose to create nucleotides. These nucleotides play a crucial role in protein synthesis and energy metabolism, highlighting the importance of this biotransformation process.

Finally, taurine, a β-amino sulphonic acid, contributes significantly to bile production. It conjugates with endogenous bile acids, adding to the composition of bile, which plays a pivotal role in digestion.

Phase II conjugation reactions neutralize harmful substances, support essential biological processes, and contribute to digestive functions, demonstrating their importance in maintaining overall health.

From Chapter 5:

article

Now Playing

5.13 : Phase II Reactions: Miscellaneous Conjugation Reactions

Pharmacokinetics: Drug Biotransformation

25 Views

article

5.1 : Drug Biotransformation: Overview

Pharmacokinetics: Drug Biotransformation

137 Views

article

5.2 : Phase I Oxidative Reactions: Overview

Pharmacokinetics: Drug Biotransformation

210 Views

article

5.3 : Phase I Reactions: Oxidation of Aliphatic and Aromatic Carbon-Containing Systems

Pharmacokinetics: Drug Biotransformation

109 Views

article

5.4 : Phase I Reactions: Oxidation of Carbon-Heteroatom and Miscellaneous Systems

Pharmacokinetics: Drug Biotransformation

44 Views

article

5.5 : Phase I Reactions: Reductive Reactions

Pharmacokinetics: Drug Biotransformation

152 Views

article

5.6 : Phase I Reactions: Hydrolytic Reactions

Pharmacokinetics: Drug Biotransformation

41 Views

article

5.7 : Phase II Conjugation Reactions: Overview

Pharmacokinetics: Drug Biotransformation

103 Views

article

5.8 : Phase II Reactions: Glucuronidation

Pharmacokinetics: Drug Biotransformation

131 Views

article

5.9 : Phase II Reactions: Sulfation and Conjugation with α-Amino Acids

Pharmacokinetics: Drug Biotransformation

106 Views

article

5.10 : Phase II Reactions: Glutathione Conjugation and Mercapturic Acid Formation

Pharmacokinetics: Drug Biotransformation

85 Views

article

5.11 : Phase II Reactions: Acetylation Reactions

Pharmacokinetics: Drug Biotransformation

113 Views

article

5.12 : Phase II Reactions: Methylation Reactions

Pharmacokinetics: Drug Biotransformation

67 Views

article

5.14 : Factors Affecting Drug Biotransformation: Physicochemical and Chemical Properties of Drugs

Pharmacokinetics: Drug Biotransformation

104 Views

article

5.15 : Factors Affecting Drug Biotransformation: Biological

Pharmacokinetics: Drug Biotransformation

68 Views

We use cookies to enhance your experience on our website.

By continuing to use our website or clicking “Continue”, you are agreeing to accept our cookies.

Learn More